A detailed history of Nisa Investment Advisors, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 122 shares of HLVX stock, worth $226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122
Previous 13 838.46%
Holding current value
$226
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$1.58 - $14.42 $172 - $1,571
109 Added 838.46%
122 $0
Q2 2024

Jul 19, 2024

BUY
$11.86 - $15.93 $106 - $143
9 Added 225.0%
13 $0
Q1 2024

May 01, 2024

BUY
$14.15 - $19.75 $56 - $79
4 New
4 $0
Q3 2023

Nov 02, 2023

BUY
$11.59 - $16.7 $150 - $217
13 New
13 $0

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $62.2M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.